KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Amortizatization of Intangibles (2018 - 2025)

Historic Amortizatization of Intangibles for Vir Biotechnology (VIR) over the last 8 years, with Q3 2025 value amounting to -$1.3 million.

  • Vir Biotechnology's Amortizatization of Intangibles fell 27146.89% to -$1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$10.1 million, marking a year-over-year decrease of 12037.12%. This contributed to the annual value of -$5.4 million for FY2024, which is 16199.17% down from last year.
  • Per Vir Biotechnology's latest filing, its Amortizatization of Intangibles stood at -$1.3 million for Q3 2025, which was down 27146.89% from -$2.5 million recorded in Q2 2025.
  • In the past 5 years, Vir Biotechnology's Amortizatization of Intangibles registered a high of $9.4 million during Q1 2023, and its lowest value of -$4.1 million during Q1 2025.
  • For the 5-year period, Vir Biotechnology's Amortizatization of Intangibles averaged around $255789.5, with its median value being -$409000.0 (2021).
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first soared by 243987.73% in 2022, then tumbled by 161806.72% in 2025.
  • Over the past 5 years, Vir Biotechnology's Amortizatization of Intangibles (Quarter) stood at -$326000.0 in 2021, then skyrocketed by 2439.88% to $7.6 million in 2022, then tumbled by 117.71% to -$1.4 million in 2023, then plummeted by 60.47% to -$2.2 million in 2024, then skyrocketed by 39.35% to -$1.3 million in 2025.
  • Its last three reported values are -$1.3 million in Q3 2025, -$2.5 million for Q2 2025, and -$4.1 million during Q1 2025.